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coverage rate among the elderly include the increase in the coverage
rate and the elimination of disparities across racial/ethnic groups.
Objective: To examine the potential effectiveness of a television (TV)
campaign to increase seasonal inﬂuenza vaccination among the
elderly. Methods: We estimated the incremental cost-effectiveness
ratio (ICER, deﬁned as incremental cost per additionally vaccinated
Medicare individual) of a hypothetical nationwide TV campaign for
inﬂuenza vaccination compared with no campaign. We measured the
effectiveness of the nationwide TV campaign (advertised once a week
at prime time for 30 seconds) during a 17-week inﬂuenza vaccination
season among four racial/ethnic elderly groups (N¼39 million): non-
Hispanic white (W), non-Hispanic African American (AA), English-
speaking Hispanic (EH), and Spanish-speaking Hispanic (SH). Results:
The hypothetical campaign cost was $5,960,000 (in 2012 US dollars).
The estimated campaign effectiveness ranged from 1.1% (the SH
group) to 1.42% (the W group), leading to an increased disparity in
inﬂuenza vaccination among non-Hispanic white and non-Hispanic
African American (W-AA) groups (0.6 percentage points), W-EH groupsee front matter & 2015 Published by Elsevier Inc.
(ISPOR).
.1016/j.jval.2015.03.1794
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lds Avenue Medical Sciences 1C, Davis, CA 95616.(0.1 percentage points), and W-SH groups (1.5 percentage points). The
estimated ICER was $23.54 (95% conﬁdence interval $14.21–$39.37) per
additionally vaccinated Medicare elderly in a probabilistic analysis.
Race/ethnicity-speciﬁc ICERs were lowest among the EH group
($22.27), followed by the W group ($22.47) and the AA group ($30.55).
The nationwide TV campaign was concluded to be reasonably cost-
effective compared with a benchmark intervention (with ICER $44.39
per vaccinated individual) of a school-located vaccination program.
Break-even analyses estimated the maximum acceptable campaign
cost to be $14,870,000, which was comparable to the benchmark ICER.
Conclusions: The results could justify public expenditures on the
implementation of a future nationwide TV campaign, which should
include multilingual campaigns, for promoting seasonal inﬂuenza
vaccination.
Keywords: cost-effectiveness, elderly population, inﬂuenza vaccination,
television campaign.
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Inﬂuenza-associated disease is a major cause of death in the
United States [1,2]. Inﬂuenza and pneumonia ranked ninth
among all causes of death for all age groups [1] and seventh for
the elderly in 2010 [3]. The elderly (65 years and older) accounted
for 90% of deaths due to ﬂu diseases [2]. In addition, the total
economic costs of inﬂuenza amounted to $29 billion annually
(adjusted to 2010 US dollars) including the direct medical costs
($10.2 billion) and the indirect costs (loss of productivity $18.8
billion) among the entire US population [4]. Speciﬁcally, the
annual burden of medical costs on the elderly was $5.5 billion
(adjusted to 2010 US dollars) [5].
Despite this, the inﬂuenza vaccination coverage rate among
the elderly has been far from the 2020 Healthy People goal of 90%
[6]. It ﬂuctuated around 70%, on average, from the 2000 to 2001
inﬂuenza season to the 2012 to 2013 inﬂuenza season [7–10]. Also,persistent racial/ethnic disparities in inﬂuenza vaccination have
been reported [7–10]. For instance, the inﬂuenza vaccination rates
among racial/ethnicity groups for the 2012 to 2013 season were
67.9%, 54.5%, and 65.8% in non-Hispanic white (W), non-Hispanic
African American (AA), and Hispanic (H) groups, respectively [9].
Disparities in inﬂuenza vaccination among W-AA and W-H
groups were 13.4 and 2.1 percentage points, respectively [9].
Several potential determinants were suggested to explain why
the vaccination rates remained at a suboptimal level among the
Medicare elderly. One potential determinant is the time cost of
vaccination, which was empirically suggested by a study of the
nationally representative Medicare elderly [11]. The importance
of time cost is also implied by the elimination of the out-of-
pocket expenditure on inﬂuenza vaccination under Medicare
since 1993 [12]. Options to reduce such time cost include a
standing order vaccination program for patients admitted to a
hospital [13] and taking advantage of clinic visits primarily foron behalf of International Society for Pharmacoeconomics and
ublic Health Sciences, University of California Davis School of
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[11]. Other potential determinants include individual-level dem-
ographic characteristics, socioeconomic factors, inﬂuenza vac-
cine supply, and inﬂuenza epidemic activity levels [11,14].
Potential determinants for racial/ethnic disparities are exempli-
ﬁed by racial/ethnic differences in perceptions about inﬂuenza
vaccination [15]. For instance, the AA elderly had a distrust of the
vaccine effectiveness [16] and hence were three times more likely to
never receive inﬂuenza vaccination during their lifetime than were
the W elderly [17]. Other determinants include less use of general
preventive care among minority groups, provider bias, and differ-
ences in vaccine availability among minority groups [14,18].
On the basis of the recent literature and the potentially large
positive impact of a nationwide television (TV) campaign, we
focused on a nationwide TV campaign in this study. Our previous
study found a strong association between nationwide TV net-
work coverage on inﬂuenza-related topics and inﬂuenza vacci-
nation among the Medicare elderly by analyzing the 1999 to 2001
Medicare Current Beneﬁciary Survey (MCBS) data [19]. In addition,
the TV campaign was reported to be generally effective in
changing health behavior (e.g., nutrition, physical activity, and
use of tobacco, alcohol, and illicit drugs) and health service
utilization (e.g., cancer screening, prevention of heart disease,
immunization programs [for measles, mumps, and rubella], and
antibiotic use) [20–22].
There were several TV campaigns to promote seasonal inﬂu-
enza vaccination, such as a Centers for Disease Control and
Prevention–promoted campaign through various media including
TV [23], a California statewide TV campaign [24], and corporate
campaigns [25]. Nevertheless, to our knowledge, the effectiveness
or the cost-effectiveness of these TV campaigns was not quanti-
tatively evaluated, probably because of the methodological difﬁ-
culties. Two foreign studies reported the effectiveness of a TV
campaign for adult vaccination. One study from Sweden reported
that the mass media campaign (including TV, newspapers, and
posters) in a local community decreased the inﬂuenza-associated
hospital treatments among the elderly [26]. The other study from
Australia found that a local TV advertisement for free pneumo-
coccal immunization (targeting community-dwelling individuals
50 years and older) statistically increased the vaccine order
among physicians by 4.5% in 2006 [27].
To our knowledge, there is no study that has performed an
economic evaluation (e.g., the cost-effectiveness) of a nationwide
TV campaign for seasonal inﬂuenza vaccination operated by a
single institution in the United States. To ﬁll the gaps in the
literature, the present study aimed to perform a cost-
effectiveness analysis to examine whether the hypothetical
nationwide TV campaign for seasonal inﬂuenza vaccination
would be reasonably cost-effective among the US Medicare
elderly as compared to no nationwide TV campaign. The present
study focuses on the Medicare elderly population, mainly
because the nationally representative data required to test the
research question are available only among the Medicare pop-
ulation. This is also because the TV campaign is expected to be
more effective among the elderly population than among the
younger population because of the following reasons: The elderly
(65 years and older) spent three times more time watching TV
than did young adults (15–64 years) in 2006 [28]. Speciﬁcally, the
elderly (65 years and older) were estimated to spend 2.9 to 4.5
hours per day (half of their leisure time) watching TV in 2012 [29].
TV was the second most widely used information source (the ﬁrst
source among mass media), after medical professionals, which
was the most popular information source, on inﬂuenza vaccina-
tion among the elderly in 2000 [30].
This study reveals 1) whether the nationwide TV campaign for
seasonal inﬂuenza vaccination is cost-effective compared with a
benchmark intervention for inﬂuenza vaccination (for details, seethe Methods section) and 2) the maximum total campaign cost
allowable to be compared with this benchmark in cost-
effectiveness. The results help justify the implementation of a
future nationwide TV campaign for seasonal inﬂuenza vaccina-
tion and possibly other vaccinations.Methods
Model Description
We developed a decision-analytical model to evaluate a hypo-
thetical nationwide TV campaign to promote seasonal inﬂuenza
vaccination among the US Medicare elderly from the societal
perspective. The societal perspective was adopted because a
federal or state government agency is more likely to ﬁnancially
support a future actual TV campaign than do other stakeholders
because of the great beneﬁts of the TV campaign for the general
public. Despite the societal perspective, we focused on the
intermediate outcome (i.e., vaccine receipt) without accounting
for ﬁnal outcomes such as inﬂuenza vaccine preventable medical
care expenditure and productivity loss among the working
population. This was because this potential cost-saving amount
depends on inﬂuenza vaccine effectiveness (varying substantially
across years owing to vaccine-antigen match), timing and
severity of epidemic activity, and other year-speciﬁc factors [31–
33]. Consequently, the present cost-effectiveness analysis focuses
on the uncertainties regarding the TV campaign’s narrowly
deﬁned cost and intermediate health outcome (i.e., vaccine
receipt), excluding another set of uncertainties regarding year-
to-year variations in potential cost savings.
This hypothetical TV campaign was assumed to be aired
during a single inﬂuenza vaccination season in 2012. The target
population is a hypothetical cohort of 2012 Medicare elderly 65
years and older (N ¼ 39 million) [34], including only four racial/
ethnic groups of non-Hispanic white (W), non-Hispanic African
American (AA), English-speaking Hispanic (EH), and Spanish-
speaking Hispanic (SH) [14,35]. Because past studies found that
disparities in inﬂuenza vaccination among the non-Hispanic white
and Hispanic groups are largely explained by language differences
[14,36–38], EH and SH individuals were distinguished on the basis
of whether Spanish was used in an interview in the MCBS.
The parameters in the decision tree model (Fig. 1) are listed in
Table 1, reﬂecting the racial/ethnic differences in parameters
including population proportion, baseline vaccination coverage
rate, and effectiveness of the TV campaign [8–10,14,35,39]. All
costs were converted to 2012 US dollars by using the consumer
price index [40]. The decision tree model was constructed using
TreeAge Pro 2013 software [41]. The MCBS data analysis used
STATA version 12 [42].
Cost Parameter
The hypothetical TV campaign costs consisted of the one-time
advertisement production cost and the broadcasting cost
(Table 1) [43,44]. The latter covered the cost of airing for 30
seconds during prime time (8:00–11:00 PM) once a week on the
three nationwide TV networks—ABC, CBS, and NBC—for 17
weeks from September 1, 2012, to December 31, 2012.
Effectiveness Parameters
Intervention effectiveness was deﬁned in two ways. The primary
analysis assumed that the increase in the vaccination rate is
multiplicative to the baseline vaccination rate. For instance, an
increase in the vaccination rate among the W vaccination group
Fig. 1 – Decision tree model. Asterisk indicates the multiplication. Cost_camp, total cost of the TV campaign; Cost per capita
(Cost_camp/POP), per capita TV campaign cost; Hispanic_e, English-speaking Hispanic; Hispanic_s, Spanish-speaking
Hispanic; Paa, baseline (vaccination rate) of the non-Hispanic African American population; Paa*Iaa, increase in vaccination
coverage rate is multiplicative to the baseline vaccination rate because of the TV campaign among the non-Hispanic African
American population; Phe, baseline (vaccination rate) of the English-speaking Hispanic population; Phe*Ihe, increase in
vaccination coverage rate is multiplicative to the baseline vaccination rate because of the TV campaign among the English-
speaking Hispanic population; Phs, baseline (vaccination rate) of the Spanish-speaking Hispanic population; Phs*Ihs, increase
in vaccination coverage rate is multiplicative to the baseline vaccination rate because of the TV campaign among the Spanish-
speaking Hispanic population; POP, total number of the Medicare elderly including four racial/ethnic groups; POPaa,
proportion of the non-Hispanic African American population; POPhe, proportion of the English-speaking Hispanic population;
POPhs, proportion of the Spanish-speaking Hispanic population; POPw, proportion of the non-Hispanic white population; Pw,
baseline (vaccination rate) of the non-Hispanic white population; Pw*Iw, increase in vaccination coverage rate is
multiplicative to the baseline vaccination rate because of the TV campaign among the non-Hispanic white population.
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Table 1 – Deﬁnitions of model parameters.
Variable Estimate Range Source
Cost of TV campaign*
Cost of TV campaign for Sep 1–Dec 31 (Cost_camp) $5,960,000 (¼ A þ (B  3  17)) $4,146,000 to
$9,988,000
A: Production cost of 30-s campaign $350,000 [43]
B: Broadcasting cost of 30-s prime time advertisement on
three nationwide networks
$110,000 $74,000 to $189,000 [44]
Baseline vaccination coverage rate without the TV campaign
Total 65.20% 59.6% to 69.6% [8–10,39]
Non-Hispanic white (Pw) 67.70% 63.2% to 71.1% [8–10,39]
Non-Hispanic African American (Paa) 50.10% 39.7% to 56.1% [8–10,39]
Hispanic
Hispanic (English speaking) (Phe) 65.50% 57.5% to 71.1% [14]
Hispanic (Spanish speaking) (Phs) 41.90% 30.7% to 52.7% [14]
Vaccination coverage rate increase (%) with the TV campaign
(primary analysis)
Non-Hispanic white (Iw) 1.42% 0.53% to 1.63% Our analysis
Non-Hispanic African American (Iaa) 0.79% 0.73% to 2.26% Our analysis
Hispanic
Hispanic (English speaking) (Ihe) 1.40% 0.58% to 1.78% Our analysis
Hispanic (Spanish speaking) (Ihs) 1.10% 4.18% to 3.07% Our analysis
Vaccination coverage rate increase (pp) with the TV campaign
(secondary analysis)
Non-Hispanic white (Iw) 0.95 pp 0.35 to 1.06 pp Our analysis
Non-Hispanic African American (Iaa) 0.39 pp 0.35 to 1.06 pp Our analysis
Hispanic
Hispanic (English speaking) (Ihe) 0.95 pp 0.35 to 1.06 pp Our analysis
Hispanic (Spanish speaking) (Ihs) 0.55 pp 2.30 to 1.06 pp Our analysis
Medicare elderly population
Total (2012) (POP) 39,037,404 [34]
Non-Hispanic white (POPw) 83.30% [35]
Non-Hispanic African American (POPaa) 9% [35]
Hispanic (7.7%) [35]
Hispanic (English speaking) (POPhe) 4.20% [14]
Hispanic (Spanish speaking) (POPhs) 3.50% [14]
Note. All costs in 2012 US dollars.
Cost_camp, total cost of TV campaign; Iaa, Increase in vaccination coverage rate among non-Hispanic African American population; Ihe,
Increase in vaccination coverage rate among English speaking Hispanic population; Ihs, Increase in vaccination coverage rate among Spanish
speaking Hispanic population; Iw, Increase in vaccination coverage rate among non-Hispanic white population; Paa, baseline (vaccination
rate) of the non-Hispanic African American population; Phe, baseline (vaccination rate) of the English-speaking Hispanic population; Phs,
baseline (vaccination rate) of the Spanish-speaking Hispanic population; POP, total number of Medicare elderly including four racial/ethnic
groups; POPaa, proportion of the non-Hispanic African American population; POPhe, proportion of the English-speaking Hispanic population;
POPhs, proportion of the Spanish-speaking Hispanic population; POPw, proportion of the non-Hispanic white population; pp, percentage point;
Pw, baseline (vaccination rate) of the non-Hispanic white population.
* Rounded to 1000.
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proportion (e.g., 0.95%  70%). The secondary analysis assumed
that the increase in the vaccination rate is additive (e.g., an
increase by 0.95 percentage points), which does not depend on
the baseline vaccination rate. We estimated the race/ethnicity-
speciﬁc multiplicative increases (primary analysis) and additive
increases (secondary analysis) in the vaccination rate by ana-
lyzing our original MCBS data. The results of primary and
secondary analyses are reported in the Results section and in
Appendix A found at http://dx.doi.org/10.1016/j.jval.2015.03.
1794, respectively.
In the primary analysis, intervention effectiveness was meas-
ured by the number of additionally vaccinated Medicare elderly,
which was calculated by multiplying 1) the number of 2012
Medicare elderly population [34] with 2) the proportion of each
racial/ethnic group [14,35], 3) the race/ethnicity-speciﬁc baseline
vaccination coverage rate, and 4) the race/ethnicity-speciﬁcchange in the vaccination rate (percentage from the baseline rate)
due to the TV campaign (Table 1). In the secondary analysis,
intervention effectiveness was measured by multiplying compo-
nent 1 with component 2 and 5) the race/ethnicity-speciﬁc change
in the vaccination rate (percentage point) due to the TV campaign,
which was independent of the baseline vaccination rate.
Components 1 and 2 were obtained from the Centers for
Medicare & Medicaid Services report, the US Census Bureau 2012
population estimates, and the literature [14,34,35]. The hypo-
thetical 2012 Medicare elderly sample included only W, AA, EH,
and SH racial/ethnic groups (N ¼ 39 million).
Component 3 was obtained from race/ethnicity-speciﬁc vac-
cination coverage rates from the 1999 to 2000 season to the 2012
to 2013 season for the total, W, and AA groups among the elderly
[8–10,39]. Because these data did not distinguish the EH and SH
groups in the Hispanic population, the vaccination coverage rate
among the EH and SH groups was obtained from our previous
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The average, minimum, and maximum rates of vaccination
coverage in those seasons were used to deﬁne parameter values
and distributions [8–10,14,39].
Components 4 and 5 were derived from our original cross-
sectional multivariate survival analyses of the 1999 to 2001 MCBS
data set [45], and the distinction was made between the EH and
SH groups (detailed results are reported in Appendix B found at
http://dx.doi.org/10.1016/j.jval.2015.03.1794). These 3 years were
chosen because they represent different levels of vaccine supply
delay/shortage; that is, no delay/shortage in the 1999 to 2000
season, severe delay/shortage in the 2001 to 2002 season, and
moderate delay/shortage in the 2002 to 2003 season [19].
Following our past study [19], we performed a multivariate
survival analysis that used the generalized gamma model
because of the following reasons: 1) implausibly large estimates
in logit models, 2) unstable estimates in Cox models that cannot
include geographic variations in covariates, and 3) Wald test
results rejecting exponential, Weibull, and log-normal models
while not rejecting gamma models. The dependent variable for
the multivariate survival analysis was vaccine receipt date
identiﬁed by analyzing Medicare claims data. This analysis aimed
to estimate the race/ethnicity-speciﬁc association between the
vaccine receipt timing (i.e., measured as the number of days from
September 1) and the “preceding” daily TV coverage on inﬂuenza,
controlling for potential confounding factors. The key covariate of
daily TV coverage was measured by counting the number of TV
program transcripts, for the three nationwide TV networks, that
included the keywords of inﬂuenza/ﬂu and vaccine delay/short-
age [19]. Other covariates included three types of media, vaccine
supply, regional/individual factors, individual demographic char-
acteristics, and socioeconomic factors [19].
The interaction terms between race/ethnicity and daily TV
coverage were tested to examine racial/ethnic differences in vacci-
nation timing. The annual vaccination rates were predicted using
the estimated coefﬁcients of parameters. Then, the incremental
effects of daily TV coverage on race/ethnicity-speciﬁc annual
vaccination rates were predicted by increasing 1 unit of daily TV
coverage. Those incremental effects of the daily TV coverage were
used as a proxy for the race/ethnicity-speciﬁc change in the
vaccination rate (percentage point) due to the TV campaign.
Cost-Effectiveness Analysis
We determined the incremental cost-effectiveness ratio (ICER)
indicating incremental dollar value (2012 US dollars) per addi-
tionally vaccinated Medicare elderly because of the TV campaign
compared with the no-TV campaign. We concluded that this TV
campaign was cost-effective if its ICER was lower than the ICER of
a similar benchmark intervention ($44.39 per additionally vacci-
nated individual) [46]. Among past similar interventions, the
selected benchmark intervention of a school-located vaccination
program was most similar to the present study in terms of its
aim, broad target population, and potential positive spillover
effect. In other words, this intervention of a school-located
vaccination program was selected as a benchmark intervention
because it aimed to motivate a broad patient population to come
to a clinic for vaccination, not targeting a narrowly deﬁned
population such as a speciﬁc insurer’s enrollees, patients visiting
a clinic, and patients admitted to a hospital. In addition, the
benchmark intervention of a school-located vaccination program
motivated not only some parents to have their child vaccinated
at a school-located vaccine clinic but also other parents to have
their child vaccinated at a physician clinic (i.e., a positive spill-
over effect beyond vaccinations at a school) [46].
Other past similar interventions targeted speciﬁc populations,
for example, a reminder intervention among a speciﬁc insurer’senrollees (ICER $3.98–$18.57 per vaccinated individual) [47], a
reminder intervention among patients admitted to a hospital
(ICER $77.07–$551.00 per vaccinated individual, including inﬂu-
enza vaccine administration cost) [48], and ﬁnancial incentives to
the primary care physicians (ICER $7.08 per vaccinated individ-
ual) [49].
The deterministic model used point estimates of all model
parameters with an assumption of no vaccine delay/shortage
during the inﬂuenza vaccination season. To address the model
parameter uncertainty, we performed 1) one-way sensitivity
analyses of the deterministic model and 2) probabilistic analyses.
One-way sensitivity analyses changed the parameter values, with
probable ranges presented in Table 1 on the basis of the literature
and our MCBS analysis. Also, break-even analyses were per-
formed to ﬁnd threshold levels for model parameters to make
the TV campaign equally or more cost-effective than the afore-
mentioned benchmark intervention. Break-even analyses were
performed using possible ranges of parameter values. These
analyses were performed for each racial/ethnic group as well as
for the whole population.
The probabilistic analyses used triangular distributions deﬁned
by likeliest values (using point estimates in a deterministic model)
and minimum and maximum values (using ranges of estimates in
one-way sensitivity analyses) for all model parameters listed in
Table 1. To address the uncertainty of parameters, the mean and
95% conﬁdence interval (CI) of the ICER were obtained by conduct-
ing Monte-Carlo simulation (10,000 iterations). If the 95% CI
included $44.39 (the value of the benchmark intervention), the
probability of ICERs (o$44.39) for 10,000 iterations was calculated.
To test the robustness of the cost-effectiveness analysis
results across racial/ethnic-speciﬁc groups, we performed
another set of sensitivity analyses, estimating ICERs unique to
each of the four racial/ethnic groups. These subpopulation
analyses examined how the effectiveness of the same TV cam-
paigns among different racial/ethnic groups affected group-
speciﬁc ICERs when the program cost (per person) is equal as in
all other analyses. All other analyses estimated and used a
common ICER estimate for all racial/ethnic groups.Results
According to the deterministic model, the nationwide TV cam-
paign for seasonal inﬂuenza vaccination increased the number of
vaccinated Medicare elderly by 335,000 (rounded to the nearest
1,000) with the incremental cost of $5,960,000, compared with no
such TV campaign, leading to the ICER of $17.79 (per additionally
vaccinated Medicare elderly) (Table 2). This ICER estimate of the
nationwide TV campaign for inﬂuenza vaccination was con-
cluded to be cost-effective, and hence preferred to the no-TV
campaign, on the basis of the fact that its ICER was smaller than
the benchmark ICER ($44.39) [46].
The probabilistic model yielded results similar to those
yielded by the deterministic model. The mean ICER for 10,000
estimates (iterations) was $23.54 (per additionally vaccinated
Medicare elderly). The upper bound of the 95% CI for these ICER
estimates, ranging from $14.21 to $39.37, was also below the
benchmark threshold ICER value ($44.39). Thus, the cost-
effectiveness of the nationwide TV campaign for inﬂuenza
vaccination was concluded to be robust to the uncertainties of
model parameters.
Table 3 summarizes the results of one-way sensitivity anal-
yses of the deterministic model. For the parameters of broad-
casting cost, baseline vaccination coverage rate, and vaccination
coverage rate increase with the TV campaign (for each of the four
racial/ethnic groups), the main ICER estimates among the whole
population (Table 2) were robust to the probable ranges of these
Table 2 – Cost-effectiveness analysis.
Model Strategy Cost
($1000)*
Incremental
cost ($1000)*
Effect (1000
persons)*
Incremental
effect (1000
persons)*
ICER ($ per
additionally
vaccinated Medicare
elderly)
Base-case model Comparator 0 25,418
Intervention 5960 5960 25,753 335 17.79
Probabilistic model
(95% CI)
Comparator 0 25,226
(24,157–26,207)
Intervention 6713
(4685–9226)
6713
(4685–9226)
25,522
(24,441–26,520)
296 (184–378) 23.54 (14.21–39.37)
Note. All costs in 2012 US dollars.
CI, conﬁdence interval; ICER, incremental cost-effectiveness ratio, indicating the cost (dollar value) per additionally vaccinated Medicare
elderly.
* Rounded to 1000.
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paign would remain more cost-effective than a benchmark
intervention (a school-located vaccination program) [46] as long
as either the total campaign cost is less than $14,870,000
(rounded to 10,000) or the vaccination coverage rate increase
with the TV campaign is greater than 0.5% at least among the W
group (not shown in the tables).
Although the nationwide TV campaign increased the overall
inﬂuenza vaccination rate among the W, AA, and EH groups, it
also increased racial/ethnic disparities in vaccination rates
because of the differential TV campaign effects on the vaccina-
tion rate. Speciﬁcally, disparities in inﬂuenza vaccination amongTable 3 – Summary of the results of one-way sensi-
tivity analyses.
Variable ICER ($ per
additionally
vaccinated
Medicare
elderly)
(low end)
ICER ($ per
additionally
vaccinated
Medicare
elderly)
(high end)
Broadcasting cost (74,431–188,974) 12.37 29.81
Vaccination coverage rate increase
with the TV campaign
Non-Hispanic white (0.53%–1.63%) 15.43 42.84
Non-Hispanic African American 16.51 17.84
(0.73%–2.26%)
English-speaking Hispanic (0.58%–
1.78%)
17.58 18.26
Spanish-speaking Hispanic
(4.18% to 3.07%)
16.59 18.79
Baseline vaccination coverage rate
without the TV campaign
Non-Hispanic white (63.2%–71.1%) 16.99 18.96
Non-Hispanic African American 17.70 17.94
(39.7%–56.1%)
English-speaking Hispanic (57.5%–
71.1%)
17.72 17.88
Spanish-speaking Hispanic
(30.7%–52.7%)
17.70 17.87
Note. All costs in 2012 US dollars. Maximum acceptable campaign
cost (when ICER ¼ $44.39) ¼ $14,874,000.
ICER, Incremental cost-effectiveness ratio, indicating the cost
(dollar value) per additionally vaccinated Medicare elderly.Non-Hispanic white and non-Hispanic African American (W-AA),
Non-Hispanic white and English-speaking Hispanic (W-EH), and
Non-Hispanic white and Spanish-speaking Hispanic (W-SH)
groups increased by 0.6, 0.1, and 1.5 percentage points, respec-
tively (Table 4).
Table 5 summarizes the results of another set of sensitivity
analyses, subpopulation analyses for each racial/ethnic group.
Among the four racial/ethnic groups examined, the TV campaign
was most cost-effective among the EH group, followed by the W
group. The ICERs estimated by the probabilistic model were
$22.27 (as the mean, with 95% CI $12.87– $39.40) and $22.47 (as
the mean, with 95% CI $13.15–$39.56) for the EH group and the W
group, respectively. All these ICER estimates, for example, the
means and the upper bounds of 95% CIs, were below the bench-
mark value ($44.39).
In contrast, the TV campaign was relatively less cost-effective
among the AA group, with the ICER being $30.55 (as the mean,
with 95% CI $15.03–$53.44). Because the 95% CI included the
benchmark threshold ICER value ($44.39), the TV campaign was
concluded to be relatively less cost-effective among the AA group
than among W and EH groups. Among the SH group, the TV
campaign was dominated by “without the TV campaign” because
of the increased cost but the decreased vaccination rate after the
TV campaign.Discussion
Our ﬁndings are expected to make two types of contributions to
the literature. One is the robust and reasonable cost-effectiveness
of the hypothetical nationwide TV campaign for seasonal inﬂu-
enza vaccination, which helps justify a future campaign. The
campaign’s ICERs ($17.79–$23.54 [per additionally vaccinated
Medicare elderly]) are lower than the benchmark ICER of $44.39
for a school-located vaccination program for elementary school
students [46]. The other contribution is that the TV campaign effect
was estimated to differ across racial/ethnic groups, leading to an
increase in racial/ethnic disparities in inﬂuenza vaccination with-
out additional considerations. Therefore, a future campaign needs
to include supplemental activities to prevent a potential increase in
racial/ethnic disparities in inﬂuenza vaccination. As discussed in
further paragraphs, the additional cost of these supplemental
activities appears less likely to change our qualitative conclusion
about the cost-effectiveness of the TV campaign.
The robustness of the estimated cost-effectiveness of the TV
campaign was quantitatively conﬁrmed by the probabilistic
model (Table 2), one-way sensitivity analyses of the deterministic
model (Table 3), the comparable results across subpopulations
Table 4 – Racial/ethnic disparity of inﬂuenza vaccination coverage.
Variable With TV
campaign
Without TV
campaign
Disparity increase
with TV campaign
Non-Hispanic white 68.70% 67.70% NA
Non-Hispanic African American (disparity with white) 50.5% (18.2%) 50.1% (17.6%) 0.6 pp
English-speaking Hispanic (disparity with white) 66.4% (2.3%) 65.5% (2.2%) 0.1 pp
Spanish-speaking Hispanic (disparity with white) 41.4% (27.3%) 41.9% (25.8%) 1.5 pp
NA, not applicable; pp, percentage point.
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effectiveness assumptions (Appendix Tables A1–A4 found at
http://dx.doi.org/10.1016/j.jval.2015.03.1794). One exception was
observed among the SH group. For this group, the TV campaign
was dominated by “the comparator (no-TV campaign)” because of
a reduction in the number of vaccinated SH elderly after the
campaign (Table 5). In addition, although still cost-effective, the
TV campaign tended to be relatively less cost-effective among the
AA group than among W and EH groups because of smaller
positive effects of the TV campaign among the AA group.
These differential TV campaign effects across racial/ethnic
groups were estimated by performing the original cross-sectional
multivariate survival analyses using MCBS data merged with the
data on TV coverage on inﬂuenza. These race/ethnicity-speciﬁc
effects were estimated with consideration of racial/ethnic differ-
ences in individual socioeconomic status and other potential
confounding factors because these factors were included as
covariates in the aforementioned multivariate survival analyses.
Two possible reasons may explain such different campaign
effects. The ﬁrst reason is applicable for the AA group and for the
SH group. Our past study found that the limited inﬂuenza vaccine
supply was positively associated with increased racial/ethnic
disparities in inﬂuenza vaccination [14]. This was possibly
because health care providers located in areas with a largerTable 5 – Subpopulation analyses: Separate cost-effectiv
Race/
ethnicity
Strategy Base-c
Cost
($1000)*
Incremental
cost ($1000)*
Eff
(10
pers
Non-Hispanic
white
Comparator 0 22,
Intervention 4965 4965 22,
Non-Hispanic
African
American
Comparator 0 1,7
Intervention 536 536 1,7
Hispanic
(English
speaking)
Comparator 0 1,0
Intervention 248 248 1,0
Hispanic
(Spanish
speaking)‡
Comparator 0 5
Intervention 211 211 5
Notes. These subpopulation analyses examined how the effectiveness of d
speciﬁc ICERs when the program cost (per person) is equal as in all oth
estimated and used a common ICER estimate for all racial/ethnic group
ICER, incremental cost-effectiveness ratio, indicating the cost (dollar val
* Rounded to 1000.
† ICER o $44.39: 90% (African American) of 10,000 iterations.
‡ “TV campaign” was dominated by “without the TV campaign.”proportion of underserved racial/ethnic populations may have
experienced a relatively greater decrease in inﬂuenza vaccine
provision than did providers in areas with a lower proportion [14].
In other words, when the TV coverage on inﬂuenza would
increase the demand for inﬂuenza vaccination [19], a relative
vaccine supply shortage might occur. Under the limited inﬂuenza
vaccine supply, all racial/ethnic minority groups would be less
likely to have access to inﬂuenza vaccine even during their clinic
visits than would the W group.
The second reason is that English is a language barrier for the
SH group [50]. The elderly in this SH group are less likely than
other racial/ethnic groups to be exposed to English TV programs
covering inﬂuenza because they are more likely to watch Spanish
TV networks. This information exposure disparity, combined
with the increased demand for inﬂuenza vaccine among all other
racial/ethnic groups, could result in the relatively limited access
to inﬂuenza vaccine among the SH group, ultimately leading to a
negative effect of the campaign among the SH group.
To prevent the potential increase in racial/ethnic disparities in
inﬂuenza vaccination, a future TV campaign needs to include
supplemental activities such as airing multilingual campaign
advertisements (e.g., on Spanish TV networks) and sustaining
vaccine delivery to safety net providers for vulnerable racial/
ethnic minority groups. Our qualitative conclusion about theeness analysis for each race/ethnic group.
ase model Monte- Carlo
simulation
ect
00
ons)*
Incremental
effect (1000
persons)*
ICER ($ per
additionally
vaccinated
Medicare
elderly)
ICER (95%
conﬁdence
interval)
014
326 312 15.88 22.47 (13.15–39.56)
60
74 14 38.57 30.55 (15.03–53.44)†
66
80 14 16.65 22.27 (12.87–39.40)
78
72 6 Dominated Dominated
ifferent TV campaigns among racial/ethnic groups affects the group-
er analyses presented in Tables 1–4. All other analyses (Tables 1–4)
s. All costs in 2012 US dollars.
ue) per additionally vaccinated Medicare elderly.
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 6 2 2 – 6 3 0 629cost-effectiveness of the TV campaign is expected to remain even
if a future TV campaign includes the additional cost of these
supplemental activities. This is partly because our break-even
analysis estimated the maximum acceptable campaign cost
(comparable to the school-located inﬂuenza vaccination pro-
gram) to be $14.9 million, which is 2.5 times greater than the
campaign cost assumed in the present analysis.
This is also partly because the positive campaign spillover
effect is highly likely to occur among the younger population
(children and adults younger than 65 years, which is a 6.3 times
larger population than the elderly population) [51]. Such addi-
tional effectiveness will make the TV campaign more cost-
effective. It is difﬁcult to estimate, however, this spillover effect
of a TV campaign because the vaccination timing data (i.e., claims
data) were available only for fragmented younger populations.
Despite no direct evidence of the TV vaccination campaign
effectiveness among the younger population, one study reported
that a TV campaign was effective for tobacco control among
nonelderly populations (younger than 65 years) [52].
As explained in the Methods section, our analysis excluded
another set of uncertainties regarding the potential cost saving
that may vary substantially across years. If inﬂuenza vaccination
is certain to decrease the direct medical expenditure by $40 per
vaccinated elderly, the focused TV campaign would be a cost-
saving intervention. A future study is expected to additionally
model these potential cost savings by inﬂuenza vaccination
subsequent to a TV campaign.
Our analyses may have three limitations. The ﬁrst is the
potentially limited external validity of the TV campaign effective-
ness based on the 1999 to 2001 data analysis that did not
explicitly account for the Internet media. Despite the increased
role of the Internet media and the relatively reduced role of TV
[53], the results of the present study are expected to be reason-
ably generalizable because of the following reasons: The recent
literature showed that the elderly still spent half of their leisure
time watching TV in 2012 [29] and that the Internet media had a
complementary relationship with the traditional mass media in
2003 [54]. Also, because our original analyses included covariates
of other media such as a wire service news agency (Associated
Press) and a nationwide newspaper (USA Today) [19], the TV
effectiveness seems less likely to be substantially overestimated.
The second limitation is the uncertainty regarding the TV
campaign effectiveness, which is potentially inﬂuenced by the
baseline vaccination rate and a delay/shortage of inﬂuenza
vaccine supply. The former issue is addressed by our model
parameter baseline vaccination rate, which was deﬁned by the
range of 14 seasons from 1999 to 2012. The latter issue is partly
addressed by our analysis that represents three levels of vaccine
supply during three seasons, that is, no, moderate, or severe
delay/shortage, as explained in the Methods section [14,19].
The third limitation is our assumption that the efﬁcacy of the
daily TV coverage on inﬂuenza-related topics is equivalent to the
effectiveness of the TV campaign. Although the validation of this
assumption needs the implementation of an actual TV campaign,
the effectiveness of the actual TV campaign could be lower than
the estimated efﬁcacy of the daily TV coverage. Because the
content of an actual TV campaign would substantially inﬂuence
the TV campaign effectiveness [55], the content will need to be
carefully designed.Conclusions
We conclude that a future nationwide TV campaign for seasonal
inﬂuenza vaccination would be reasonably cost-effective when
the cost-effectiveness was evaluated among the Medicare elderly
only. Although the TV campaign would increase the overallvaccination coverage rates among the Medicare elderly, the
differential TV campaign effect across racial/ethnic groups would
lead to increased racial/ethnic disparities in vaccination. To
prevent the potential increase in racial/ethnic disparities in
inﬂuenza vaccination, a future TV campaign needs to include
supplemental activities such as airing multilingual campaign
advertisements (e.g., on Spanish TV networks), local campaigns/
outreach programs, and sustaining vaccine delivery to safety net
providers for vulnerable racial/ethnic minority groups.
Our qualitative conclusion about the TV campaign cost-
effectiveness is expected to be robust, even if a future TV campaign
accounts for the additional cost of these supplemental activities
that are not included in the present study. This is partly because the
maximum acceptable campaign cost is 2.5 times greater than the
campaign cost assumed in the present study and partly because the
positive campaign spillover effect is highly likely to occur among a
younger population other than the Medicare elderly.
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